Straits Times Index
3,322.62 +14.72 (+0.45%) S&P 500
5,312.84 +5.83 (+0.11%) Dow
39,394.55 -276.49 (-0.70%) Nasdaq
16,904.71 +103.16 (+0.61%) Bitcoin USD
68,087.82 -1,875.53 (-2.68%) CMC Crypto 200
1,464.69 -37.98 (-2.53%)
JanOne Inc. (JAN)
| Previous close | 3.3100 |
| Open | 3.2000 |
| Bid | 2.9000 x 100 |
| Ask | 3.2300 x 100 |
| Day's range | 2.8100 - 3.2000 |
| 52-week range | 0.2200 - 5.2600 |
| Volume | |
| Avg. volume | 266,277 |
| Market cap | 26.882M |
| Beta (5Y monthly) | 2.04 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
JanOne Closes Acquisition of ALT 5 Sigma Inc., a Leading Next Generation Blockchain Fintech
JanOne Inc. (Nasdaq: JAN) announced today it has closed its previously announced acquisition of blockchain financial technology provider, ALT 5 Sigma Inc., and each of its wholly-owned subsidiaries.
- PR Newswire
JanOne to Acquire ALT 5 Sigma Inc., a Leading Next Generation Blockchain Financial Technology Provider
JanOne Inc. (Nasdaq: JAN) announced today that it has executed a Definitive Agreement to acquire blockchain financial technology provider, ALT 5 Sigma Inc., a Delaware corporation, and each of its wholly-owned subsidiaries. The transaction is anticipated to close the week of May 13th, 2024 and is subject to customary closing conditions and regulatory requirements as applicable.
- PR Newswire
JanOne Regains Compliance with Nasdaq's Listing Requirements
JanOne (Nasdaq: JAN), the biopharmaceutical company focused on developing non-addicting painkillers and novel treatments for the causes of pain, today announced that on March 13, 2024 it received a notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market Inc. ("Nasdaq") indicating that the Company had regained compliance with the minimum bid price requirement set forth in Rule 5550(a)(2) of the Nasdaq Listing Rules (the "Minimum Bid Price Requirement").
